Skip to main content

The Treatment of Pain and Addiction Utilizing Education and Proper Prescribing: The New Paradigm Continued

Credits
up to 3.5 AMA CME credits, 4.2 Nursing Contact Hours, 3 hours CPE credit*, 4.2 Nursing Pharmacology hours or 3.5 ADA CERP Dentistry credits
This course was reviewed and accepted by
West Virginia Board of Medicine
West Virginia Board of Osteopathic Medicine
West Virginia Board of Dentistry
West Virginia University School of Nursing
West Virginia Board of Pharmacy*
Credit Fee
$45
Target Audience
The course is designed for all clinicians—physicians, dentists, nurses, physician assistants and others—who prescribe opioid medications and who care for patients receiving opioid medications.

Enroll Now

Following completion of this web course, participants should be able to:

  • recognize addictive illness is common among patients with other medical illnesses
  • analyze pain and prescription drug abuse current statistics
  • recognize that outcomes improve with the treatment of pain, addictive and psychiatric illnesses concurrently
  • discuss pain and addictive illness epidemiology with chronic pain and misuse of opioids
  • enumerate trends in opioid addiction, overdose deaths and opioid prescribing and recognize factors that led to increased prescribing of opioids
  • identify concerns about long-term use of opioids for chronic non-cancer pain
  • recognize addictive illness and its impact on prescribing, opioid misuse and overdose deaths
  • state specific statutory requirements including rules and regulations of the West Virginia Board of Pharmacy, West Virginia Board of Medicine and West Virginia Board of Osteopathic Medicine relating to controlled substance prescribers
  • recognize legislative changes; compliance with controlled substance laws and rules related to substance abuse and prescription drug abuse
  • display and follow the steps necessary to register, log-on and use West Virginia's controlled substance monitoring program
  • identify recent updates to the controlled substance monitoring program
  • ascertain and discuss current West Virginia statistics on prescription drug diversion, abuse, intoxications and resulting deaths
  • enumerate the synergy of opioids and other common drugs of abuse related to overdose deaths
  • process the markedly increasing role of heroin to overdose deaths relative to the proper opioid prescribing and increased utilization of the PDMP
  • recognize the importance of utilizing the WV Board of Pharmacy query to detect “doctor shopping” and diversion behaviors
  • explain the epidemiology of overdose
  • explain the rationale for and scope of overdose prevention education and naloxone rescue kit distribution
  • explain the legal and policy environment regarding furnishing naloxone rescue kits
  • incorporate overdose prevention education and naloxone rescue kits into medical and pharmacy practice
  • discuss case studies on best practices for indication of opioids in chronic pain treatment and general characteristics, including toxicities and drug interactions
  • discuss case studies on risk assessment and tools and examination and evaluation of the pain patient
  • discuss case studies on the initiation and ongoing management of the chronic pain patient treated with opioid based therapies
  • explain the utilization of urine drug testing in the monitoring of compliance /drug diversion in pain patients
  • identify behaviors of doctor shopping and drug diversion and best practices of prescribing of controlled substances.

Instructions

Participants who are not WVU Faculty or Staff, you will fill out your name, email address, and phone number, and SOLE will automatically email you a password. Check your spam and junk box, as they occasionally end up there. Once you have your password, you can log in with your full email address (i.e. ce@wvu.edu) and the password from the email.

*This course is not approved as an ACPE course. This course is designed to meet the WV CE requirement on drug diversion training as stipulated by the WV Board of Pharmacy.